Wave Life Sciences (WVE) Preferred Stock Liabilities (2016 - 2025)
Historic Preferred Stock Liabilities for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $7.9 million.
- Wave Life Sciences' Preferred Stock Liabilities changed 0.0% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.9 million for FY2024, which is 0.0% changed from last year.
- Per Wave Life Sciences' latest filing, its Preferred Stock Liabilities stood at $7.9 million for Q3 2025, which was down 0.0% from $7.9 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Preferred Stock Liabilities peaked at $7.9 million during Q1 2021, and registered a low of $7.9 million during Q1 2021.
- In the last 5 years, Wave Life Sciences' Preferred Stock Liabilities had a median value of $7.9 million in 2021 and averaged $7.9 million.
- Within the past 5 years, the most significant YoY rise in Wave Life Sciences' Preferred Stock Liabilities was 0.0% (2021), while the steepest drop was 0.0% (2021).
- Wave Life Sciences' Preferred Stock Liabilities (Quarter) stood at $7.9 million in 2021, then changed by 0.0% to $7.9 million in 2022, then changed by 0.0% to $7.9 million in 2023, then changed by 0.0% to $7.9 million in 2024, then changed by 0.0% to $7.9 million in 2025.
- Its Preferred Stock Liabilities stands at $7.9 million for Q3 2025, versus $7.9 million for Q2 2025 and $7.9 million for Q1 2025.